Estatística Cardiovascular – Brasil 2020

Oliveira, Gláucia Maria Moraes de; Brant, Luísa Campos Caldeira; Polanczyk, Carísi Anne; Biolo, Andréia; Nascimento, Bruno Ramos; Malta, Déborah Carvalho; Souza, Maria de Fátima Marinho de; Soares, Gabriel Porto; Xavier, Gesner Francisco; Machline-Carrion, M. Julia; Bittencourt, Márcio Sommer; Neto, Octávio Marques Pontes; Silvestre, Odílson Marcos; Teixeira, Renato Azeredo; Sampaio, Roney Orismar; Gaziano, Tom; Roth, Gregory A.; Ribeiro, Antônio Luiz Pinho

doi:10.36660/abc.20200812

Cited by 125 publications

(99 citation statements)

References 238 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There is no definitive diagnostic test, and clinical criteria show high sensitivity and low specificity (16). These factors, together with the difficulty of accessing health services in low-income countries, explain the relatively low acutephase diagnostic rate and low number of patients included in studies (1)(2)(3)(4)(5).…”

Section: Discussionmentioning

confidence: 99%

“…Data on the prevalence of rheumatic fever are probably underreported due to (a) the cost of screening, (b) difficulties in acute rheumatic disease diagnosis and (c) data on surgery or mortality representing rheumatic fever incidence from 2 decades ago. Chronic valvular heart disease is the most feared consequence of rheumatic fever, leading to a decreased quality of life, hospitalizations, and surgical procedures, primarily in young adults (1)(2)(3)(4)(5).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients

Rosa

Lopes

Spina

et al. 2021

Front. Cardiovasc. Med.

Self Cite

View full text Add to dashboard Cite

Background: Heart failure occurs in ~10% of patients with acute rheumatic fever (RF), and several studies have shown that cardiac decompensation in RF results primarily from valvular disease and is not due to primary myocarditis. However, the literature on this topic is scarce, and a recent case series has shown that recurrent RF can cause ventricular dysfunction even in the absence of valvular heart disease.Methods: The present study evaluated the clinical, laboratory and imaging characteristics of 25 consecutive patients with a clinical diagnosis of myocarditis confirmed by 18F-FDG PET/CT or gallium-67 cardiac scintigraphy and RF reactivation according to the revised Jones Criteria. Patients underwent three sequential echocardiograms at (1) baseline, (2) during myocarditis and (3) post corticosteroid treatment. Patients were divided according to the presence (Group 1) or absence (Group 2) of reduced left ventricular ejection fraction (LVEF) during myocarditis episodes.Results: The median age was 42 (17–51) years, 64% of patients were older than 40 years, and 64% were women. Between Group 1 (n = 16) and in Group 2 (n = 9), there were no demographic, echocardiographic or laboratory differences except for NYHA III/IV heart failure (Group 1: 100.0% vs. Group 2: 50.0%; p = 0.012) and LVEF (30 [25–37] vs. 56 [49–62]%, respectively; p < 0.001), as expected. Group 1 patients showed a significant reduction in LVEF during carditis with further improvement after treatment. There was no correlation between LVEF and valvular dysfunction during myocarditis. Among all patients, 19 (76%) underwent 18F-FDG PET/CT, with a positive scan in 68.4%, and 21 (84%) underwent gallium-67 cardiac scintigraphy, with positive uptake in 95.2%, there was no difference between these groups.Conclusion: Myocarditis due to rheumatic fever reactivation can cause left ventricular dysfunction despite valvular disease, and it is reversible after corticosteroid treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients

Rosa

Lopes

Spina

et al. 2021

Front. Cardiovasc. Med.

Self Cite

View full text Add to dashboard Cite

show abstract

“…As Doenças Cardiovasculares (DCV) são aquelas que afetam o sistema circulatório, constituindo a principal causa de morte no mundo (ROTH et al, 2018). A definição de DCV agrupa três principais causas: Doença Isquêmica do Coração (DIC) ou Infarto do Miocárdio (IM), em sua forma aguda; Acidente Vascular Cerebral (AVC) e Insuficiência Cardíaca (IC) (OLIVEIRA et al, 2020). Nesse contexto, o entendimento sobre DCV se faz importante, na medida em que suas complicações possuem impacto na perda de produtividade no trabalho e na redução da renda familiar, bem como em que seus custos têm impactos no orçamento do sistema de saúde devido ao uso de medicamentos e internações hospitalares (ROHDE et al, 2018;MALTA et al, 2020;OLIVEIRA et al, 2020).…”

Section: Introductionunclassified

“…Cabe destacar, ainda, que a estatística realizada entre 1990 e 2017 mostrou que as DCV foram a principal causa de óbito no Brasil e que a letalidade foi mais prevalente por DIC, seguida de AVC. Em 2017, todas as Unidades Federativas brasileiras tiveram a DIC como principal causa de óbito (OLIVEIRA et al, 2020). Dentre as DCV, o IAM foi a que teve o maior custo, com aproximadamente 22,4 bilhões de reais, em 2015 (STEVENS et al, 2018).…”

Section: Introductionunclassified

O conhecimento de leigos sobre os sinais e sintomas do infarto agudo do miocárdio: revisão integrativa / Laymen's knowledge about the signs and symptoms of acute myocardial infarction: an integrative review

Sousa¹,

Guimarães²,

Gomes³

et al. 2021

BJDV

View full text Add to dashboard Cite

RESUMOO Infarto Agudo do Miocárdio é uma doença isquêmica de apresentação frequente na população, responsável por elevada mortalidade e despesa no setor saúde. Nesse sentido, é oportuno que leigos conheçam os seus sinais e sintomas, a fim de realizar o manejo adequado dos acometidos pela doença. O objetivo do estudo foi revisar, com base na literatura científica, os principais sinais e sintomas do Infarto Agudo do Miocárdio e o nível de reconhecimento destes pela população. Trata-se de uma revisão integrativa da literatura realizada nas bases e bancos de dados Medline, Lilacs, Science Direct e Embase, mediada pelos descritores: "Sinais e Sintomas", "Identificação da Emergência" e "Infarto

show abstract

“…The article highlights firstly that there has been an increase in the annual change in proportional mortality from ischemic heart disease in women in recent years, with an age-standardized incidence of 104 per 100 000 population for males and 58 per 100 000 population for females. [1][2] Although it is well known that there are important differences between men and women in the prevalence of risk factors for cardiovascular disease (CVD), studies have focused attention on older women with more comorbidities such as hypertension, dyslipidemia, diabetes, heart failure, and atrial fibrillation, demonstrating that smoking and diabetes mellitus have a more substantial impact on women. Moreover, postmenopausal hormonal changes play an important role in women's CVD.…”

mentioning

confidence: 99%

How the Gender Gap Affects the Incidence and Prognosis of Cardiovascular Disease

Gazzilli¹

2021

International Journal of Cardiovascular Sciences

View full text Add to dashboard Cite

show abstract

Estatística Cardiovascular – Brasil 2020

Cited by 125 publications

References 238 publications

Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients

Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients

O conhecimento de leigos sobre os sinais e sintomas do infarto agudo do miocárdio: revisão integrativa / Laymen's knowledge about the signs and symptoms of acute myocardial infarction: an integrative review

How the Gender Gap Affects the Incidence and Prognosis of Cardiovascular Disease

Contact Info

Product

Resources

About